Pages that link to "Q41089488"
Jump to navigation
Jump to search
The following pages link to Cholesterol inhibition, cancer, and chemotherapy (Q41089488):
Displaying 50 items.
- Statins and fibrates for preventing melanoma (Q24245521) (← links)
- Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis (Q24294300) (← links)
- Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway (Q24302433) (← links)
- The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst (Q24796000) (← links)
- HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2 (Q28201997) (← links)
- Molecular link between cholesterol, cytokines and atherosclerosis (Q33946830) (← links)
- Cholesterol-receptor-mediated genomics in health and disease (Q34269604) (← links)
- HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis (Q34605246) (← links)
- Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells (Q34687592) (← links)
- Multitasking of the 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor: beyond cardiovascular diseases (Q35602774) (← links)
- In vitro Anti-Tumor Effects of Statins on Head and Neck Squamous Cell Carcinoma: A Systematic Review (Q35670621) (← links)
- Impact of cholesterol on disease progression (Q35850911) (← links)
- Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease (Q35910859) (← links)
- p53 regulates the mevalonate pathway in human glioblastoma multiforme. (Q36246455) (← links)
- The antitumour activities of statins (Q36256400) (← links)
- Suppression by pravastatin, an inhibitor of p21ras isoprenylation, of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats (Q36291719) (← links)
- Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer (Q36499925) (← links)
- Multi-Target Approaches in Colon Cancer Chemoprevention Based on Systems Biology of Tumor Cell-Signaling. (Q37349574) (← links)
- Combinatorial strategies employing nutraceuticals for cancer development (Q37906730) (← links)
- Targeting tumor cell metabolism with statins. (Q37981833) (← links)
- The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics (Q38149124) (← links)
- Lovastatin-induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal (Q39130783) (← links)
- Simvastatin impairs murine melanoma growth. (Q39619441) (← links)
- Activation of the integrated stress response regulates lovastatin-induced apoptosis (Q40094100) (← links)
- Advances in ether phospholipids treatment of cancer (Q40492996) (← links)
- Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) mice (Q41018564) (← links)
- Lovastatin induces apoptosis in malignant mesothelioma cells. (Q41039948) (← links)
- Receptor-Ck-dependent regulation of genes in HL-60 cell line (Q41069554) (← links)
- Marketed drugs used for the management of hypercholesterolemia as anticancer armament (Q41080847) (← links)
- Risk of multiple myeloma in a case-spouse study (Q41284957) (← links)
- CAAX-box protein, prenylation process and carcinogenesis (Q42069148) (← links)
- Activation of liver X receptors prevents statin-induced death of 3T3-L1 preadipocytes (Q42812928) (← links)
- Effect of simvastatin alone and in combination with cytosine arabinoside on the proliferation of myeloid leukemia cell lines (Q43691171) (← links)
- Hypocholesterolemia: a risk factor for mortality? (Q44263927) (← links)
- Isoprenoid pathway related cascade in multiple myeloma (Q44511410) (← links)
- Migration, proliferation, and invasion of human glioma cells following treatment with simvastatin (Q44577207) (← links)
- Hypothalamic digoxin, hemispheric chemical dominance, and oncogenesis: evidence from multiple myeloma (Q44645416) (← links)
- Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study (Q47124829) (← links)
- Receptor-Ck controls the expression of Bcl-2 and cyclin d genes (Q47783376) (← links)
- Receptor-Ck and leukemogenesis (Q47886867) (← links)
- Security and maximal tolerated doses of fluvastatin in pediatric cancer patients (Q48760131) (← links)
- Statin use does not prevent recurrent adenomatous polyp formation in a VA population (Q49113359) (← links)
- Human platelets contain a novel 47 kDa thiol-oxidase having affinity for genomic sterol-regulatory sequence (Q54196460) (← links)
- Cerebrotendinous xanthomatosis: a critical update (Q57341492) (← links)
- Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis (Q58723469) (← links)
- Hsa-miR-10a-5p downregulation in mutant UQCRB-expressing cells promotes the cholesterol biosynthesis pathway (Q58771216) (← links)
- Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma (Q64242985) (← links)
- Lymphocytes from CML patients lack a 47 kDa factor having affinity for a genomic sterol regulatory sequence (Q71874679) (← links)
- Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation (Q72681167) (← links)
- Receptor-'Ck' dependent signalling regulates the LDL-receptor gene transcription (Q73195034) (← links)